Concepts (114)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Failure, Chronic | 4 | 2007 | 68 | 0.850 |
Why?
|
| Kidney | 5 | 2011 | 275 | 0.410 |
Why?
|
| Renal Dialysis | 4 | 2007 | 52 | 0.400 |
Why?
|
| Graft Rejection | 2 | 2007 | 33 | 0.350 |
Why?
|
| Kidney Diseases | 2 | 2011 | 59 | 0.350 |
Why?
|
| Anti-Retroviral Agents | 2 | 2006 | 15 | 0.340 |
Why?
|
| Polyomavirus Infections | 1 | 2007 | 6 | 0.290 |
Why?
|
| Cause of Death | 1 | 2007 | 66 | 0.290 |
Why?
|
| Heart Transplantation | 1 | 2007 | 42 | 0.280 |
Why?
|
| Calcineurin | 1 | 2006 | 7 | 0.260 |
Why?
|
| HIV Infections | 1 | 2006 | 146 | 0.230 |
Why?
|
| Proton-Translocating ATPases | 4 | 1997 | 7 | 0.230 |
Why?
|
| Nifedipine | 2 | 1994 | 12 | 0.230 |
Why?
|
| Verapamil | 2 | 1993 | 9 | 0.220 |
Why?
|
| Cardiovascular Diseases | 1 | 2007 | 346 | 0.220 |
Why?
|
| Inflammation | 1 | 2007 | 601 | 0.210 |
Why?
|
| Carboplatin | 2 | 1994 | 106 | 0.210 |
Why?
|
| Cisplatin | 2 | 1994 | 172 | 0.200 |
Why?
|
| Kidney Function Tests | 3 | 2007 | 19 | 0.170 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 2 | 1996 | 50 | 0.160 |
Why?
|
| Kidney Transplantation | 4 | 2011 | 43 | 0.160 |
Why?
|
| Hyperkalemia | 2 | 1997 | 8 | 0.160 |
Why?
|
| Kidney Tubules | 2 | 1996 | 21 | 0.150 |
Why?
|
| H(+)-K(+)-Exchanging ATPase | 1 | 1996 | 1 | 0.130 |
Why?
|
| Colon | 1 | 1996 | 119 | 0.120 |
Why?
|
| Tolmetin | 1 | 1994 | 2 | 0.120 |
Why?
|
| Tromethamine | 1 | 1994 | 2 | 0.120 |
Why?
|
| Analgesics | 1 | 1994 | 34 | 0.120 |
Why?
|
| Cimetidine | 1 | 1994 | 2 | 0.110 |
Why?
|
| Diatrizoate Meglumine | 1 | 1993 | 1 | 0.110 |
Why?
|
| Ioxaglic Acid | 1 | 1993 | 2 | 0.110 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 1994 | 72 | 0.110 |
Why?
|
| Acute Kidney Injury | 1 | 1994 | 73 | 0.110 |
Why?
|
| Calcium Channel Blockers | 1 | 1994 | 36 | 0.110 |
Why?
|
| Dehydration | 1 | 1992 | 6 | 0.100 |
Why?
|
| Acidosis, Renal Tubular | 3 | 1997 | 3 | 0.100 |
Why?
|
| Male | 8 | 2007 | 12869 | 0.100 |
Why?
|
| Rats | 5 | 1997 | 1545 | 0.100 |
Why?
|
| Humans | 13 | 2011 | 26826 | 0.090 |
Why?
|
| Animals | 8 | 2011 | 9960 | 0.090 |
Why?
|
| Microcirculation | 1 | 2011 | 111 | 0.090 |
Why?
|
| Kidney Tubules, Proximal | 1 | 1990 | 13 | 0.090 |
Why?
|
| Urography | 1 | 1990 | 12 | 0.090 |
Why?
|
| Contrast Media | 1 | 1990 | 93 | 0.080 |
Why?
|
| Graft Survival | 2 | 2006 | 27 | 0.080 |
Why?
|
| Rats, Wistar | 3 | 1994 | 145 | 0.080 |
Why?
|
| Risk Factors | 3 | 2007 | 2010 | 0.080 |
Why?
|
| Antineoplastic Agents | 1 | 1994 | 657 | 0.070 |
Why?
|
| Immunohistochemistry | 2 | 2007 | 453 | 0.070 |
Why?
|
| Autopsy | 1 | 2007 | 24 | 0.070 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2007 | 14 | 0.070 |
Why?
|
| Multicenter Studies as Topic | 1 | 2007 | 42 | 0.070 |
Why?
|
| Fatal Outcome | 1 | 2007 | 66 | 0.070 |
Why?
|
| Prognosis | 2 | 2006 | 759 | 0.070 |
Why?
|
| C-Reactive Protein | 1 | 2007 | 93 | 0.070 |
Why?
|
| Survival Analysis | 1 | 2007 | 276 | 0.070 |
Why?
|
| AIDS-Associated Nephropathy | 1 | 2006 | 3 | 0.070 |
Why?
|
| HIV | 1 | 2006 | 11 | 0.070 |
Why?
|
| Calcineurin Inhibitors | 1 | 2006 | 4 | 0.070 |
Why?
|
| HIV-1 | 1 | 2006 | 54 | 0.070 |
Why?
|
| Severity of Illness Index | 1 | 2007 | 445 | 0.060 |
Why?
|
| Disease Progression | 1 | 2007 | 450 | 0.060 |
Why?
|
| Immunosuppressive Agents | 1 | 2006 | 140 | 0.060 |
Why?
|
| Middle Aged | 4 | 2007 | 6817 | 0.060 |
Why?
|
| Acetylglucosaminidase | 2 | 1993 | 2 | 0.050 |
Why?
|
| Alkaline Phosphatase | 2 | 1993 | 31 | 0.050 |
Why?
|
| gamma-Glutamyltransferase | 2 | 1993 | 18 | 0.050 |
Why?
|
| Time Factors | 1 | 2007 | 1562 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2007 | 624 | 0.050 |
Why?
|
| Postoperative Complications | 1 | 2007 | 604 | 0.050 |
Why?
|
| Sjogren's Syndrome | 2 | 1995 | 256 | 0.050 |
Why?
|
| Kidney Tubules, Distal | 3 | 1997 | 3 | 0.050 |
Why?
|
| United States | 1 | 2007 | 2032 | 0.050 |
Why?
|
| Female | 6 | 2007 | 14462 | 0.050 |
Why?
|
| Kidney Tubules, Collecting | 2 | 1997 | 4 | 0.040 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 1 | 1997 | 3 | 0.040 |
Why?
|
| Lupus Nephritis | 1 | 1997 | 99 | 0.030 |
Why?
|
| Loop of Henle | 1 | 1996 | 1 | 0.030 |
Why?
|
| Kidney Medulla | 1 | 1996 | 2 | 0.030 |
Why?
|
| Kidney Cortex | 1 | 1996 | 5 | 0.030 |
Why?
|
| Gastric Mucosa | 1 | 1996 | 35 | 0.030 |
Why?
|
| Ileum | 1 | 1996 | 23 | 0.030 |
Why?
|
| Hypokalemia | 1 | 1995 | 2 | 0.030 |
Why?
|
| Swine | 1 | 1996 | 220 | 0.030 |
Why?
|
| Ketorolac Tromethamine | 1 | 1994 | 3 | 0.030 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 1994 | 25 | 0.030 |
Why?
|
| Drug Combinations | 1 | 1994 | 50 | 0.030 |
Why?
|
| Intestinal Mucosa | 1 | 1996 | 186 | 0.030 |
Why?
|
| Aged | 3 | 1994 | 5166 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1996 | 545 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 1996 | 316 | 0.030 |
Why?
|
| Membranes, Artificial | 1 | 1993 | 26 | 0.030 |
Why?
|
| Lipid Peroxidation | 1 | 1993 | 47 | 0.030 |
Why?
|
| Injections, Intraperitoneal | 1 | 1992 | 34 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2011 | 48 | 0.020 |
Why?
|
| beta 2-Microglobulin | 1 | 1990 | 5 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 1990 | 65 | 0.020 |
Why?
|
| Enzymes | 1 | 1990 | 22 | 0.020 |
Why?
|
| Adult | 4 | 1997 | 7382 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2011 | 305 | 0.020 |
Why?
|
| Mice | 1 | 1996 | 4406 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2006 | 68 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2006 | 41 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2011 | 1393 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2006 | 367 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2011 | 1344 | 0.010 |
Why?
|
| Incidence | 1 | 2006 | 545 | 0.010 |
Why?
|
| Proton Pumps | 1 | 1997 | 2 | 0.010 |
Why?
|
| Acid-Base Equilibrium | 1 | 1997 | 10 | 0.010 |
Why?
|
| Cattle | 1 | 1997 | 383 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1995 | 110 | 0.010 |
Why?
|
| Autoantibodies | 1 | 1997 | 466 | 0.010 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 1 | 1993 | 5 | 0.010 |
Why?
|
| Aging | 1 | 1993 | 945 | 0.000 |
Why?
|